Clinical trial
A Phase 1b Study of OPT101 in Patients With Type 1 Diabetes
NCT05428943 is registered in ClinicalTrials.gov with Op-T LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1b Study of OPT101 in Patients With Type 1 Diabetes
- Lead sponsor
- Op-T LLC
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- September 27, 2022
- Completion date
- February 21, 2024
- Enrollment
- 24 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.